SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Merck
Merck
Page 2 of 9
Leadership
Former Merck CEO Ken Frazier on the responsibility of CEOs to uphold principles despite politics
By
Fortune Editors
November 9, 2023
Health
U.S. cancer patients face nationwide shortages of life-saving chemo drugs as ‘race to the bottom’ makes their production unprofitable
By
Christiaan Hetzner
October 28, 2023
Leadership
Ken Frazier, long one of the few Black Fortune 500 CEOs, is fighting against ‘the vestiges of the way this country was run for 400 years’
By
Trey Williams
October 3, 2023
Newsletters
Hiring managers say they support dropping college degree requirements, but few actually do so. The reasons why might surprise you
By
Ruth Umoh
September 13, 2023
Health
Overwhelmed by a massive outbreak, China authorizes emergency use of Merck COVID pill Lagevrio
By
Bloomberg
December 30, 2022
Finance
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
By
Paige McGlauflin
August 15, 2022
Commentary
It’s time for companies to do less
By
Daryl Brewster
May 5, 2022
Health
The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By
Sy Mukherjee
and
IDEA Pharma
April 20, 2022
Health
A new batch of COVID pills are in focus as daily life reopens. Here’s how the treatments work—and how well
By
Jason Gale
,
John Lauerman
and
Bloomberg
February 15, 2022
Health
New York City will home-deliver free antiviral pills to COVID-19 patients
By
Ian Fisher
and
Bloomberg
January 31, 2022
Health
FDA authorizes Merck COVID pill a day after approving Pfizer’s
By
Matthew Perrone
and
The Associated Press
December 23, 2021
Health
FDA set to authorize Pfizer and Merck COVID pills this week
By
Josh Wingrove
,
Jennifer Jacobs
,
Robert Langreth
and
Bloomberg
December 21, 2021
Health
GSK says its COVID antibody therapy works against Omicron. Here’s what other drugmakers say about their treatments
By
Sophie Mellor
December 7, 2021
Health
Germany will make COVID vaccinations mandatory if Angela Merkel gets her way
By
Christiaan Hetzner
December 2, 2021
Health
Merck says its breakthrough COVID-19 pill doesn’t work nearly as well as previously reported
By
Fiona Rutherford
and
Bloomberg
November 26, 2021
Most Popular
Economy
Markets sold off after Powell said six words investors don’t want to hear: ‘Equity prices are fairly highly valued’
By
Jim Edwards
AI
Cathie Wood says the AI race has already shrunk to the 'Big 4' key players, and it could soon drop to 2
By
Marco Quiroz-Gutierrez
Economy
Millions of Americans brace for shock as Obamacare bills could soar by 75% in 2026
By
Ashley Lutz